https://www.ksdds.org 1.0 monthly 2025-12-11 https://www.ksdds.org/conference 1.0 monthly 2025-03-19 https://www.ksdds.org/become-a-member 1.0 monthly 2025-01-17 https://www.ksdds.org/registration-confirmation-kcsoo 1.0 monthly 2024-09-06 https://www.ksdds.org/2023-conference 1.0 monthly 2025-03-19 https://www.ksdds.org/2022-exhibitors 1.0 monthly 2025-03-19 https://www.ksdds.org/cme-information 1.0 monthly 2024-10-11 https://www.ksdds.org/member-portal 1.0 monthly 2025-02-17 https://www.ksdds.org/2025-conference 1.0 monthly 2025-10-23 https://www.ksdds.org/2023-exhibitors 1.0 monthly 2025-03-19 https://www.ksdds.org/2024-conference 1.0 monthly 2025-03-19 https://www.ksdds.org/2024-exhibitors 1.0 monthly 2025-03-19 https://www.ksdds.org/articles 1.0 monthly 2024-11-08 https://www.ksdds.org/2025-exhibitors 1.0 monthly 2025-10-06 https://www.ksdds.org/2025-cme-accreditation-statement 1.0 monthly 2025-10-23 https://www.ksdds.org/privacy-policy 1.0 monthly 2025-11-06 https://www.ksdds.org/2025-photos 1.0 monthly 2025-10-23 https://www.ksdds.org/accessibility-statement 1.0 monthly 2025-11-06 https://www.ksdds.org/blog/advancing-repigmentation-therapy-extended-phase-three-results-for-ruxolitinib-cream 0.8 monthly 2025-12-11 https://www.ksdds.org/blog/a-letter-from-president-matthew-fink 0.8 monthly 2025-12-11 https://www.ksdds.org/blog/research-summary-hydrocolloid-dressing-vs-petroleum-ointment-for-scar-appearance-after-dermatologic-surgery-a-randomized-clinical-trial 0.8 monthly 2025-12-11 https://www.ksdds.org/rituximab-dosing-in-pemphigus 0.8 monthly 2025-12-11 https://www.ksdds.org/atopic-dermatitis 0.8 monthly 2025-08-15 https://www.ksdds.org/efficacy-and-safety-of-secukinumab-for-moderate-to-severe-hidradenitis-suppurativa-a-review-of-a-phase-3-randomized-clinical-trial 0.8 monthly 2025-07-07 https://www.ksdds.org/extended-half-life-antibodies-the-future-of-biologic-therapy-in-atopic-dermatitis 0.8 monthly 2025-06-19 https://www.ksdds.org/dupilumab-for-prurigo-nodularis-a-randomized-clinical-trial 0.8 monthly 2025-05-14 https://www.ksdds.org/cost-eectiveness-analysis-of-3d-total-body-photography-for-people-at-high-risk-of-melanoma 0.8 monthly 2025-04-16 https://www.ksdds.org/a-review-on-an-association-of-childhood-obesity-or-weight-change-with-early-onset-follicular-occlusion-triad-in-children 0.8 monthly 2025-03-17 https://www.ksdds.org/car-t-cell-therapy-in-autoimmune-diseases 0.8 monthly 2025-02-17 https://www.ksdds.org/zasocitinib-and-plaque-psoriasis 0.8 monthly 2025-01-17 https://www.ksdds.org/neurocutaneous-melanosis-ncm 0.8 monthly 2024-12-19 https://www.ksdds.org/recent-study-in-low-dose-naltrexone-use-in-biopsy-proven-lichen-planus-of-the-nails 0.8 monthly 2024-11-08 https://www.ksdds.org/2024-poster-presentation-winners 0.8 monthly 2024-11-08 https://www.ksdds.org/kaposi-sarcoma-in-a-men-who-have-sex-with-men-patient-without-human-immunodeficiency-virus-who-was-treated-with-upadacitinib-for-ulcerative-colitis 0.8 monthly 2024-11-08